Fig. 5From: Prognostic value of systemic inflammatory markers in ovarian Cancer: a PRISMA-compliant meta-analysis and systematic reviewMeta-analysis of impact of PNR on progression-free survival of patients with ovarian cancer. a In multivariate model; (b) In univariate modelBack to article page